136 results
-
List item
Human medicine European public assessment report (EPAR): Keppra
levetiracetam, Epilepsy
Date of authorisation: 29/09/2000, Revision: 53, Authorised, Last updated: 22/03/2023Keppra Nervous System Diseases Central … assessment report (EPAR) for Keppra. It explains how the The committee … the conditions of use for Keppra. What is Keppra? Keppra is a medicine that contains … -
List item
Press release: EMA recommends measures to ensure safe use of Keppra oral solution
CHMP, Last updated: 14/10/2016measures to ensure safe use of Keppra oral solution … measures to ensure safe use of Keppra oral solution … appropriate:] 3 – How to take Keppra Always take this medicine … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Actavis
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,
, Revision: 18, Authorised, Last updated: 01/07/2022
authorised in the EU called Keppra. Expand section Collapse section … with the reference medicine, Keppra, and do not need to be repeated … to the reference medicine, Keppra. Two medicines are bioequivalent … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Sun
levetiracetam, Epilepsy
Date of authorisation: 14/12/2011,, Revision: 17, Authorised, Last updated: 24/06/2022
authorised in the EU called Keppra. How is Levetiracetam Sun … with the reference medicine, Keppra, and do not need to be repeated … shown to be comparable to Keppra. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm
levetiracetam, Epilepsy
Date of authorisation: 26/08/2011,, Revision: 14, Authorised, Last updated: 10/06/2022
authorised in the EU called Keppra. How is Levetiracetam ratiopharm … with the reference medicine, Keppra, and do not need to be repeated … to the reference medicine, Keppra. Two medicines are bioequivalent … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Actavis Group (updated)
levetiracetam, Epilepsy
Date of authorisation: 04/12/2011,, Revision: 17, Authorised, Last updated: 01/06/2023
authorised in the EU called Keppra. How is Levetiracetam Actavis … with the reference medicine, Keppra, and do not need to be repeated … and to be bioequivalent to Keppra. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Teva
levetiracetam, Epilepsy
Date of authorisation: 25/08/2011,, Revision: 19, Authorised, Last updated: 06/07/2022
authorised in the EU called Keppra. How is Levetiracetam Teva … with the reference medicine, Keppra, and do not need to be repeated … and to be bioequivalent to Keppra. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Hospira
levetiracetam, Epilepsy
Date of authorisation: 07/01/2014,, Revision: 23, Authorised, Last updated: 15/06/2022
authorised in the EU called Keppra. Expand section Collapse section … with the reference medicine, Keppra, and do not need to be repeated … shown to be comparable to Keppra. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Matever
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 26, Authorised, Last updated: 09/06/2022
European Union (EU) called Keppra. What is Matever used for … to the reference medicine, Keppra. Two medicines are bioequivalent … and to be bioequivalent to Keppra. Therefore, the Committee … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Accord
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 15, Authorised, Last updated: 24/03/2023
authorised in the EU called Keppra. How is Levetiracetam Accord … with the reference medicine, Keppra, and do not need to be repeated … and to be bioequivalent to Keppra. Therefore, the Agency’s … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2016
CHMP, Last updated: 14/10/2016measures to ensure safe use of Keppra oral solution … -
List item
National expert: Raffaella Sardelli, Italian Medicines Agency (updated)
- Declaration of interests - 39.64 KB | PDF
- Curriculum Vitae - 31.8 KB | PDF
“Contaminazione da alluminio in soluzioni di albumina umana: un monitoraggio … dell’attivatore della precallicreina in soluzioni di albumina umana” (Abs … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2011
CHMP, Last updated: 22/07/2011Levetiracetam Accord is a generic of Keppra. … Levetiracetam Accord is a generic of Keppra. • Levetiracetam Actavis … Levetiracetam Actavis is a generic of Keppra. • Matever (levetiracetam … -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 26-28 June 2006
CHMP, Last updated: 29/06/2006Keppra … supranuclear palsy. Keppra (levetiracetam), from UCB … newly diagnosed epilepsy. Keppra was first authorised in the … -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 20-23 March 2006
CHMP, Last updated: 24/03/2006Keppra … vomiting in chemotherapy. § Keppra (levetiracetam), from UCB … juvenile myoclonic epilepsy. Keppra was first authorised in the … -
List item
National expert: Eraldo Donnarumma, Italian Medicines Agency (updated)
- Declaration of interests - 39.3 KB | PDF
- Curriculum Vitae - 25.83 KB | PDF
PANORAMI E PERCORSI) “Doping: soluzione o inganno chimico? (BIF n.4/2006 … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2011
CHMP, Last updated: 20/05/2011medicines are generics of Keppra. … medicines are generics of Keppra. Positive opinion for extension … -
List item
National expert: Armando Magrelli, Italian Medicines Agency (updated)
- Declaration of interests - 39.3 KB | PDF
- Curriculum Vitae - 50.53 KB | PDF
Country: Italy Employer: Con Soluzioni Con Srl • Start date: 042004 • … -
List item
Recommendations on medication errors
Last updated: 24/06/2020 -
List item
National expert: Wim Van Paesschen, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 44.7 KB | PDF
- Curriculum Vitae - 106.5 KB | PDF
-
List item
Referral: Veterinary medicinal products containing N-methyl pyrrolidone as an excipient
Article 82
Status: European Commission final decision, opinion/position date: 08/12/2022, EC decision date: 28/03/2023, Last updated: 14/04/2023 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 December 2008
CHMP, Last updated: 18/12/2008authorised antiepileptic medicines Keppra (levetiracetam), Lyrica (pregabalin … -
List item
Referral: Closamectin Pour-on Solution and associated names
ivermectin, closantel, Article 78
Status: European Commission final decision, opinion/position date: 08/10/2015, EC decision date: 22/03/2016, Last updated: 31/05/2016 -
List item
Referral: Fiprex
fipronil, Article 33
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 14/07/2014, Last updated: 14/08/2014 -
List item
Referral: Tylosin injection for mastitis
tylosin, Article 35
Status: European Commission final decision, opinion/position date: 16/03/2017, EC decision date: 10/07/2017, Last updated: 31/07/2017